Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...